GWPH GW Pharmaceuticals plc Stock Quote

GWPH [NASD]

Healthcare | Drug Manufacturers - General | United Kingdom

Index	-	P/E	-	EPS (ttm)	-1.73	Insider Own	0.64%	Shs Outstand	31.36M	Perf Week	2.81%
Market Cap	4.49B	Forward P/E	337.38	EPS next Y	0.42	Insider Trans	-91.59%	Shs Float	30.87M	Perf Month	16.70%
Income	-53.90M	PEG	-	EPS next Q	-0.82	Inst Own	84.50%	Short Float	9.58%	Perf Quarter	46.25%
Sales	488.10M	P/S	9.19	EPS this Y	97.60%	Inst Trans	0.16%	Short Ratio	7.18	Perf Half Y	9.84%
Book/sh	23.42	P/B	6.05	EPS next Y	122.70%	ROA	-6.10%	Target Price	182.50	Perf Year	22.26%
Cash/sh	15.17	P/C	9.34	EPS next 5Y	-	ROE	-7.50%	52W Range	67.98 - 144.00	Perf YTD	22.78%
Dividend	-	P/FCF	-	EPS past 5Y	19.00%	ROI	-15.90%	52W High	-1.60%	Beta	2.05
Dividend %	-	Quick Ratio	4.30	Sales past 5Y	59.60%	Gross Margin	92.90%	52W Low	108.44%	ATR	5.81
Employees	901	Current Ratio	5.10	Sales Q/Q	50.70%	Oper. Margin	-10.00%	RSI (14)	71.37	Volatility	4.89% 4.48%
Optionable	Yes	Debt/Eq	0.02	EPS Q/Q	12.40%	Profit Margin	-11.00%	Rel Volume	0.68	Prev Close	138.42
Shortable	Yes	LT Debt/Eq	0.02	Earnings	Nov 03 BMO	Payout	-	Avg Volume	411.89K	Price	141.70
Recom	1.80	SMA20	13.16%	SMA50	13.58%	SMA200	23.07%	Volume	278,472	Change	2.37%

Aug-25-20

Initiated

Raymond James

Mkt Perform

Aug-07-20

Reiterated

Needham

Buy

$190 → $180

Jul-15-20

Downgrade

Stifel

Buy → Hold

$150 → $140

Jun-30-20

Reiterated

Evercore ISI

Outperform

$250 → $275

Jun-01-20

Resumed

Oppenheimer

Outperform

$173 → $166

Apr-08-20

Initiated

Northland Capital

Outperform

$128

Mar-06-20

Initiated

Citigroup

Buy

$192

Oct-30-19

Initiated

H.C. Wainwright

Buy

$170

Oct-21-19

Initiated

Needham

Buy

$200

May-07-19

Upgrade

Oppenheimer

Perform → Outperform

May-07-19

Reiterated

Guggenheim

Buy

$186 → $222

May-07-19

Reiterated

Cantor Fitzgerald

Overweight

$196 → $229

Mar-18-19

Reiterated

Cantor Fitzgerald

Overweight

$193 → $196

Jan-02-19

Initiated

JP Morgan

Overweight

$134

Nov-05-18

Resumed

Piper Jaffray

Overweight

Sep-28-18

Reiterated

BofA/Merrill

Buy

$181 → $197

Sep-07-18

Resumed

Morgan Stanley

Overweight

Aug-15-18

Initiated

Stifel

Buy

$181

Aug-08-18

Reiterated

Cantor Fitzgerald

Overweight

$235 → $211

Apr-19-18

Reiterated

Cantor Fitzgerald

Overweight

$192 → $205

Jan-16-21 09:25AM	The Week In Cannabis: Stocks Spike By Double Digits On Earnings, Strong Sales, Financings Benzinga
Jan-13-21 10:37AM	Cannabis Companies Entered 2021 With A Bang Benzinga
Jan-12-21 06:36AM	5 Marijuana Stocks With the Most Cash in 2021 Motley Fool +6.73%
Jan-11-21 07:21AM	GW Pharmaceuticals provides upbeat total and Epidiolex sales outlooks; stock turns up MarketWatch
07:00AM	GW Pharmaceuticals Provides Preliminary Fourth Quarter and Full-Year 2020 Net Product Sales Results and 2021 Program Milestones GlobeNewswire
06:08AM	Your 3 Best Profit Opportunities in 2021 Motley Fool
Jan-09-21 03:23AM	Are Institutions Heavily Invested In GW Pharmaceuticals plc's (NASDAQ:GWPH) Shares? Simply Wall St.
Jan-05-21 12:24PM	CORRECTING and REPLACING - GW Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire
07:30AM	GW Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-30-20 08:43AM	Is GW Pharmaceuticals (GWPH) a Smart Long-term Buy? Insider Monkey
Dec-21-20 11:30AM	JAMA Neurology Publishes Phase 3 Study of EPIDIOLEX® (cannabidiol) Oral Solution in Patients with Seizures Associated with Tuberous Sclerosis Complex GlobeNewswire
Dec-19-20 06:36AM	5 Marijuana Stocks With Upside of 49% to 83%, According to Wall Street Motley Fool
Dec-16-20 05:33PM	Is GWPH A Good Stock To Buy Now? Insider Monkey
Dec-07-20 07:00AM	GW Pharmaceuticals to Present at the 2020 Needham Virtual Epilepsy & Pain Specialty CNS Therapeutics Conference GlobeNewswire
Dec-04-20 12:54PM	Investors: The Marijuana Boom Is Now Zacks
Dec-03-20 01:39PM	PreMarket Prep Stock Of The Day: GW Pharmaceuticals Benzinga
Dec-02-20 06:08PM	Top 5 Cannabis Stocks To Buy Now Insider Monkey
Dec-01-20 12:00PM	Top ETF of November & Its Best Stocks Zacks
08:30AM	Greenwich Biosciences to Present Data on EPIDIOLEX® (cannabidiol) Oral Solution at the American Epilepsy Society Annual Meeting GlobeNewswire
Nov-30-20 07:32AM	GW Pharmaceuticals to Present at the Evercore ISI 2020 Healthcare Conference GlobeNewswire +7.99%
Nov-25-20 12:52AM	When Can We Expect A Profit From GW Pharmaceuticals plc (NASDAQ:GWPH)? Simply Wall St.
Nov-17-20 09:40AM	Findit Features Members Global WholeHealth Partners, WynCore and OTC Tip Reporter ACCESSWIRE
Nov-13-20 01:31PM	Should You Buy Cannabis Stocks & ETFs Now? Zacks
08:30AM	Greenwich Biosciences to Present Analysis of Three Clinical Studies of Nabiximols for People with Multiple Sclerosis Related Spasticity at the American Academy of Physical Medicine and Rehabilitation (AAPM&R) Annual Assembly GlobeNewswire
Nov-09-20 07:30AM	GW Pharmaceuticals to Present at the Stifel 2020 Virtual Healthcare Conference GlobeNewswire
Nov-04-20 04:23PM	This Pot Stock Continued A Two-Day Run Here's Why Investor's Business Daily
12:53PM	Why cannabis continues to be a bipartisan issue Yahoo Finance Video
09:26AM	2020 elections: 5 states pass legal marijuana measures, potentially growing industry by $9 billion Yahoo Finance
02:36AM	GWPH Explodes 21% As Epidiolex Roars Back Through The Pandemic SmarterAnalyst
Nov-03-20 07:00PM	GW Pharmaceuticals PLC (GWPH) Q3 2020 Earnings Call Transcript Motley Fool +21.19%
01:58PM	GW Pharma shares rally on earnings and news of late-stage trial of cannabis-based treatment for MS patients MarketWatch
01:01PM	How GW Pharmaceuticals Blew Away Expectations With Its Q3 Results Motley Fool
01:01PM	GW Pharmaceuticals Initiates Phase 3 Trial for Multiple Sclerosis Drug Motley Fool
11:03AM	GW Pharma Shares Up After Loss Narrows, Revenue Rises TheStreet.com
07:47AM	GW Pharmaceuticals loss narrows more than expected and revenue beats; stock rallies MarketWatch
07:30AM	GW Pharmaceuticals stock set to rally after Phase 3 trial of MS treatment to start, after COVID-19-related delay MarketWatch
07:30AM	GW Pharmaceuticals plc Reports Third Quarter 2020 Financial Results and Operational Progress GlobeNewswire
07:15AM	GW Pharmaceuticals Initiates Pivotal Phase 3 Study of Nabiximols for Multiple Sclerosis-Associated Spasticity GlobeNewswire
06:30AM	GW Pharmaceuticals Plc to Host Earnings Call ACCESSWIRE
Nov-02-20 10:47AM	DENTSPLY SIRONA (XRAY) to Post Q3 Earnings: What's in Store? Zacks
10:43AM	AmerisourceBergen (ABC) to Post Q4 Earnings: What's in Store? Zacks
10:18AM	A Preview Of GW Pharmaceuticals's Earnings Benzinga
08:50AM	Why Earnings Season Could Be Great for GW Pharmaceuticals (GWPH) Zacks
08:50AM	Invitae (NVTA) to Report Q3 Earnings: What's in the Cards? Zacks
Oct-30-20 11:15AM	McKesson (MCK) to Post Q2 Earnings: What's in the Offing? Zacks
Oct-29-20 11:34AM	Top Marijuana Stocks on the NASDAQ for November 2020 Investopedia
Oct-27-20 10:36AM	OPKO Health (OPK) to Report Q3 Earnings: What's in Store? Zacks
Oct-26-20 08:00AM	Livongo Health (LVGO) to Post Q3 Earnings: What's in Store? Zacks
07:56AM	Baxter (BAX) to Report Q3 Earnings: What's in the Cards? Zacks
07:54AM	Stryker (SYK) to Report Q3 Earnings: What's in the Cards? Zacks
Oct-22-20 10:34AM	GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Third Quarter Ending September 30th, 2020 and Host Conference Call on November 3rd, 2020 GlobeNewswire
Oct-21-20 08:00AM	Greenwich Biosciences, Inc., a Subsidiary of GW Pharmaceuticals plc, Launches unspoken symphony, a Breakthrough Innovation Created for the US Epilepsy Community GlobeNewswire
Oct-19-20 10:39AM	Hedge Funds Are Getting Out Of GW Pharmaceuticals plc (GWPH) Insider Monkey
Oct-16-20 11:02AM	3 Marijuana Stocks to Buy With Decriminalization on the Table InvestorPlace
Oct-15-20 02:45PM	GW Pharmaceuticals Could Bottom Out Into Year-End TheStreet.com
Oct-12-20 09:50AM	New CBD Rules In Australia Bode Well For Overall Market, Observers Say Benzinga
Oct-10-20 10:45AM	What Type Of Returns Would GW Pharmaceuticals'(NASDAQ:GWPH) Shareholders Have Earned If They Purchased Their SharesYear Ago? Simply Wall St.
Sep-23-20 08:05AM	The Daily Biotech Pulse: Coronavirus Vaccine Updates From J&J & MediciNova, Australian Regulatory Nod For GW Pharma Benzinga
08:00AM	GW Pharmaceuticals: Buy the Dip? Motley Fool
03:54AM	GW Pharmaceuticals receives Australian Therapeutic Goods Administration (TGA) approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy GlobeNewswire
Sep-15-20 07:52AM	GW Pharmaceuticals Has Been Basing but Needs More Development TheStreet.com
Sep-10-20 04:00PM	Greenwich Biosciences to Share Results of Cannabis Use Survey Conducted with the North American Research Committee on Multiple Sclerosis (NARCOMS) at Joint ACTRIMS-ECTRIMS Meeting, MSVirtual2020 GlobeNewswire
04:00PM	Greenwich Biosciences to Present Data on Safety and Efficacy of Nabiximols in Persons with Multiple Sclerosis-Associated Spasticity at the Joint ACTRIMS-ECTRIMS Meeting, MSVirtual2020 GlobeNewswire
07:08AM	3 Cannabis Stocks to Avoid Like the Plague in September Motley Fool
07:00AM	GW Pharmaceuticals Announces the Appointment of David Gryska to its Board of Directors GlobeNewswire
Sep-03-20 06:30AM	Better Cannabis Stock: Charlotte's Web vs. GW Pharmaceuticals Motley Fool
Sep-02-20 01:24PM	Marijuana Medicine: Thrilling Time for Investors Zacks
Sep-01-20 07:00AM	GW Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Aug-29-20 06:41AM	Can GW Pharmaceuticals Stock Bounce Back? Motley Fool
Aug-26-20 12:38PM	Rock star Growth Puts GW Pharmaceuticals (NASDAQ:GWPH) In A Position To Use Debt Simply Wall St.
Aug-24-20 07:21AM	3 Cannabis Stocks Billionaires Were Buying in Q2 Motley Fool
Aug-16-20 10:47AM	2 Top Pharma Stocks to Buy in August Motley Fool
Aug-07-20 11:24AM	GW Pharma shares slide 12% after company swings to loss during pandemic MarketWatch -17.21%
07:34AM	The Daily Biotech Pulse: Novavax Vaccine Deals, Trevena Awaits FDA Decision, 2 IPOs Benzinga
Aug-06-20 04:44PM	GW Pharmaceuticals: Q3 Earnings Insights Benzinga
04:00PM	GW Pharmaceuticals plc Reports Second Quarter 2020 Financial Results and Operational Progress GlobeNewswire
Aug-03-20 03:45PM	Why GW Pharmaceuticals Stock Is Up Today Motley Fool
03:36PM	GW Pharmaceuticals' Epidiolex Wins New FDA Approvals Motley Fool
02:05PM	GW Pharma's stock rallies after its cannabinoid drug gets a new FDA approval MarketWatch
01:01PM	Did Hedge Funds Make The Right Call On GW Pharmaceuticals plc (GWPH) ? Insider Monkey
07:00AM	FDA Approves EPIDIOLEX® (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex GlobeNewswire
01:29AM	GW Pharma Scores New FDA Approval For CBD Drug Epidiolex SmarterAnalyst
Aug-02-20 09:34AM	Should Investors Buy GW Pharma Stock Right Now? Motley Fool
Jul-30-20 11:53AM	Will Epidolex Drive GW Pharmaceuticals' (GWPH) Q2 Earnings? Zacks
Jul-26-20 09:54AM	The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings Benzinga
08:10AM	2 Top Pot Stocks to Buy in a Recession Motley Fool
Jul-25-20 06:56AM	3 Biotech Stocks With Big Incoming Catalysts Motley Fool
Jul-23-20 07:00AM	GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Second Quarter Ending June 30th, 2020 and Host Conference Call on August 6th, 2020 GlobeNewswire
Jul-21-20 03:09PM	FDA releases guidelines for cannabis-related research, but CBD will have to wait MarketWatch
Jul-17-20 04:21PM	Better Buy: GW Pharmaceuticals vs. Corbus Pharmaceuticals Motley Fool
12:27PM	Doctors Ethan Russo And Dale Hunt Join Robert Clarke To Launch Cannabis IP-Licensing Firm Benzinga
09:05AM	Why Cannabis Stocks May See Better Days Investopedia
Jul-15-20 06:51PM	GW Pharmaceuticals Meets 80-Plus Relative Strength Rating Benchmark Investor's Business Daily
08:22AM	GW Pharmaceuticals stock slips after Stifel analyst backs off long-standing bullish view MarketWatch
Jul-14-20 08:08AM	Could GW Pharmaceuticals Be a Millionaire-Maker Stock? Motley Fool +5.56%
Jul-13-20 07:21AM	The First Pot Stock to Hit $1 Billion in Annual Sales Will Be...? Motley Fool
Jul-12-20 09:34AM	Better Cannabis Play: GW Pharmaceuticals vs. Innovative Industrial Properties Motley Fool
08:24AM	Can Mixed Fundamentals Have A Negative Impact on GW Pharmaceuticals plc (NASDAQ:GWPH) Current Share Price Momentum? Simply Wall St.
Jul-11-20 07:48AM	Got $5,000? These 2 Market-Beating Pot Stocks Are Still Hot Buys Right Now Motley Fool
Jul-09-20 06:49AM	3 Marijuana Stock Winners in the First Half of 2020 That Are Still Great Picks Motley Fool

GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform. Its lead product is Epidiolex, an oral medicine for the treatment of refractory childhood epilepsies, Dravet syndrome, and Lennox-Gastaut syndrome, as well as in phase III clinical trials for the treatment of tuberous sclerosis complex. The company also develops and markets Sativex for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of for schizophrenia, autism spectrum disorder, and neonatal hypoxic ischemic encephalopathy. It primarily operates in Europe, the United Kingdom, the United States, and internationally. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
George Adam D.	Secretary	Jan 19	Option Exercise	9.61	9,600	92,256	19,600	Jan 20 08:00 PM
George Adam D.	Secretary	Jan 19	Sale	11.68	9,600	112,128	10,000	Jan 20 08:00 PM
Knappertz Volker	Chief Medical Officer	Jan 19	Sale	11.67	6,000	70,020	17,940	Jan 20 08:00 PM
George Adam D.	Secretary	Jan 15	Option Exercise	10.06	79,860	803,683	89,860	Jan 20 08:00 PM
George Adam D.	Secretary	Jan 15	Sale	11.73	79,860	936,754	10,000	Jan 20 08:00 PM
George Adam D.	Secretary	Jan 13	Option Exercise	0.37	675,744	252,710	685,744	Jan 15 08:00 PM
George Adam D.	Secretary	Jan 13	Sale	11.03	675,744	7,454,009	10,000	Jan 15 08:00 PM
Brown Cabot	Director	Jan 04	Option Exercise	0.00	3,576	5	10,776	Jan 06 09:31 PM
Secor Alicia	Director	Jan 04	Option Exercise	0.00	3,576	5	10,140	Jan 06 09:31 PM
MACKEY CATHERINE J	Director	Jan 04	Option Exercise	0.00	3,576	5	10,092	Jan 06 09:31 PM
GUY GEOFFREY W DR	Executive Chairman	Dec 08	Sale	10.74	240,000	2,577,294	4,781,521	Dec 14 09:30 PM
GUY GEOFFREY W DR	Executive Chairman	Dec 07	Sale	11.00	480,000	5,282,364	5,021,521	Dec 14 09:30 PM
Snyder Douglas B.	Chief Legal Officer	Dec 07	Sale	11.01	26,904	296,290	0	Dec 09 08:00 PM
Tovey Christopher J.	Chief Operating Officer	Dec 01	Option Exercise	0.00	28,560	37	31,056	Dec 02 09:00 PM
Tovey Christopher J.	Chief Operating Officer	Dec 01	Sale	11.76	28,560	335,747	2,496	Dec 02 09:00 PM
Tovey Christopher J.	Chief Operating Officer	Nov 30	Option Exercise	0.00	93,468	122	95,964	Dec 02 09:00 PM
Tovey Christopher J.	Chief Operating Officer	Nov 30	Sale	11.67	93,468	1,090,772	2,496	Dec 02 09:00 PM
Knappertz Volker	Chief Medical Officer	Nov 24	Sale	10.50	12,000	126,000	23,940	Nov 25 08:00 PM
Gover Justin D.	Chief Executive Officer	Nov 17	Option Exercise	0.00	42,708	56	498,761	Nov 17 09:00 PM
Gover Justin D.	Chief Executive Officer	Nov 17	Sale	10.03	42,708	428,361	456,053	Nov 17 09:00 PM
Gover Justin D.	Chief Executive Officer	Nov 16	Option Exercise	0.00	22,800	30	478,853	Nov 17 09:00 PM
Gover Justin D.	Chief Executive Officer	Nov 16	Sale	10.02	22,800	228,456	456,053	Nov 17 09:00 PM
Gover Justin D.	Chief Executive Officer	Nov 13	Option Exercise	0.00	42,984	56	499,037	Nov 17 09:00 PM
Gover Justin D.	Chief Executive Officer	Nov 13	Sale	10.01	42,984	430,270	456,053	Nov 17 09:00 PM
Gover Justin D.	Chief Executive Officer	Nov 12	Option Exercise	0.00	64,308	84	520,361	Nov 12 09:00 PM
Gover Justin D.	Chief Executive Officer	Nov 12	Sale	10.01	64,308	643,723	456,053	Nov 12 09:00 PM
Knappertz Volker	Chief Medical Officer	Nov 11	Sale	10.00	6,000	60,000	35,940	Nov 13 08:00 PM
Gover Justin D.	Chief Executive Officer	Nov 09	Option Exercise	0.00	7,200	9	463,253	Nov 12 09:00 PM
Gover Justin D.	Chief Executive Officer	Nov 09	Sale	10.00	7,200	72,000	456,053	Nov 12 09:00 PM
Knappertz Volker	Chief Medical Officer	Nov 04	Sale	9.17	6,000	55,020	41,940	Nov 05 08:00 PM
GUY GEOFFREY W DR	Executive Chairman	Nov 03	Option Exercise	0.00	307,152	399	5,808,673	Nov 05 09:08 PM
GUY GEOFFREY W DR	Executive Chairman	Nov 03	Sale	8.48	307,152	2,605,990	5,501,521	Nov 05 09:08 PM
Snyder Douglas B.	Chief Legal Officer	Sep 30	Sale	8.13	14,400	117,072	26,904	Oct 02 04:40 PM
Snyder Douglas B.	Chief Legal Officer	Aug 11	Sale	9.40	24,000	225,600	41,304	Aug 12 08:06 PM
Snyder Douglas B.	Chief Legal Officer	Aug 10	Option Exercise	0.00	131,544	171	122,364	Aug 12 08:06 PM
Knappertz Volker	Chief Medical Officer	Aug 04	Sale	11.11	6,000	66,660	47,940	Aug 06 08:01 PM
Knappertz Volker	Chief Medical Officer	Jul 20	Sale	11.42	6,000	68,520	53,940	Jul 22 08:00 PM
Snyder Douglas B.	Chief Legal Officer	Jul 06	Sale	10.50	9,804	102,942	0	Jul 08 08:00 PM
Knappertz Volker	Chief Medical Officer	Jun 17	Sale	10.35	18,000	186,300	59,940	Jun 19 08:02 PM
Gover Justin D.	Chief Executive Officer	Jun 15	Option Exercise	0.00	4,164	5	458,129	Jun 17 08:00 PM
GUY GEOFFREY W DR	Executive Chairman	May 29	Sale	10.25	720,000	7,376,400	5,501,521	Jun 02 08:00 PM
Cline Darren S	U.S. Chief Commercial Officer	May 28	Option Exercise	0.00	7,356	9	7,356	May 29 08:00 PM
Knappertz Volker	Chief Medical Officer	May 18	Option Exercise	0.00	133,620	160	139,092	May 20 08:02 PM
Giacobello Scott M.	Chief Financial Officer	May 18	Option Exercise	0.00	116,604	140	140,742	May 20 08:01 PM
Giacobello Scott M.	Chief Financial Officer	Mar 13	Buy	6.80	7,200	48,960	88,224	Mar 17 06:07 PM
GUY GEOFFREY W DR	Executive Chairman	Mar 13	Sale	6.63	600,000	3,978,000	6,221,521	Mar 17 06:05 PM
Gover Justin D.	Chief Executive Officer	Mar 02	Option Exercise	0.00	47,844	62	599,369	Mar 04 06:01 PM
Snyder Douglas B.	Chief Legal Officer	Mar 02	Sale	8.32	2,568	21,366	67,296	Mar 04 06:03 PM
MACKEY CATHERINE J	Director	Mar 02	Sale	8.35	1,356	11,323	16,392	Mar 04 06:04 PM
Brown Cabot	Director	Mar 02	Sale	8.24	3,144	25,907	17,088	Mar 04 06:03 PM
Gover Justin D.	Chief Executive Officer	Mar 02	Sale	8.33	32,856	273,789	566,513	Mar 04 06:01 PM
Secor Alicia	Director	Mar 02	Sale	8.34	1,296	10,809	16,440	Mar 04 06:02 PM
Giacobello Scott M.	Chief Financial Officer	Mar 02	Sale	8.34	2,220	18,515	81,024	Mar 04 06:00 PM
Knappertz Volker	Chief Medical Officer	Mar 02	Sale	8.32	3,420	28,454	79,392	Mar 04 06:01 PM
Snyder Douglas B.	Chief Legal Officer	Feb 26	Sale	9.17	3,876	35,550	69,864	Feb 28 06:06 PM
Gover Justin D.	Chief Executive Officer	Feb 26	Sale	9.05	12,000	108,558	551,525	Feb 28 06:02 PM
Knappertz Volker	Chief Medical Officer	Feb 26	Sale	9.18	3,012	27,636	82,812	Feb 28 06:02 PM
Giacobello Scott M.	Chief Financial Officer	Feb 26	Sale	9.17	3,852	35,323	83,244	Feb 28 06:01 PM
Gover Justin D.	Chief Executive Officer	Feb 03	Option Exercise	0.00	202,224	263	765,749	Feb 05 05:00 PM
Gover Justin D.	Chief Executive Officer	Feb 03	Sale	9.62	202,224	1,944,678	563,525	Feb 05 05:00 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience